Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Salvages Deal With Guidant: $4 Bil. Shaved Off Purchase Price

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson's renegotiated deal to acquire Guidant for $21.5 bil. will make medical devices the firm's largest business segment once the merger closes

You may also be interested in...



Guidant Shareholders To Vote On J&J Offer; Boston Scientific Still Interested

Guidant's board of directors has formally endorsed Johnson & Johnson's $21.5 bil. takeover bid while simultaneously agreeing to enter into discussions with Boston Scientific on its $25 bil. competing offer

Guidant Shareholders To Vote On J&J Offer; Boston Scientific Still Interested

Guidant's board of directors has formally endorsed Johnson & Johnson's $21.5 bil. takeover bid while simultaneously agreeing to enter into discussions with Boston Scientific on its $25 bil. competing offer

Boston Scientific Offers $25 Bil. To Nab Guidant From J&J

Convinced that Johnson & Johnson is undervaluing Guidant, Boston Scientific made an offer of $25 bil. for the cardiovascular device firm on Dec. 5 - approximately $3 bil. more than J&J has agreed to pay

Related Content

UsernamePublicRestriction

Register

MT022920

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel